Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
crawled date : 2021 - 11 - 04 save search
Review by Journal of Neuroscience Shows No Evidence of Data Manipulation in Technical Paper Foundational to Cassava Sciences’ Lead Drug Candidate
Published: 2021-11-04 (Crawled : 14:00) - globenewswire.com
SAVA | $19.61 -7.46% -8.06% 1.3M
|
Health Technology
|
| O: 21.78%
H: 44.93%
C: 22.32%
drug
Research Frontiers Reports Third Quarter 2021 Financial Results
Published: 2021-11-04 (Crawled : 20:00) - smartglass.com
REFR | $1.56 -1.89% -1.92% 49K
|
Electronic Technology
|
| O: 1.15%
H: 12.73%
C: 12.27%
financial results results research
Primo Water Corporation Announces Third Quarter 2021 Results and Planned Exit of its North American Single-Use Retail Bottled Water Business
Published: 2021-11-04 (Crawled : 11:00) - prnewswire.com
PRMW | $18.43 1.71% 0.0% 800K
|
Consumer Non-Durables
|
| O: 3.6%
H: 11.37%
C: 11.31%
PRMW | $18.43 1.71% 0.38% 800K
|
Consumer Non-Durables
|
| O: 3.6%
H: 11.37%
C: 11.31%
results
United States Bottled Water Market Report 2021-2025: Data and Analysis putting the U.S. Market in Context of the Global Perspective
Published: 2021-11-04 (Crawled : 14:00) - prnewswire.com
PRMW | $18.43 1.71% 0.0% 800K
|
Consumer Non-Durables
|
| O: 3.6%
H: 11.37%
C: 11.31%
PRMW | $18.43 1.71% 0.38% 800K
|
Consumer Non-Durables
|
| O: 3.6%
H: 11.37%
C: 11.31%
PEP | $174.1 1.06% 1.05% 6.6M
|
Consumer Non-Durables
|
| O: -0.05%
H: 0.21%
C: 0.05%
Cybin Granted DEA Schedule I Manufacturing License
Published: 2021-11-04 (Crawled : 12:15) - biospace.com/
CYBN | $0.3677 -0.6% 0.35% 1.8M
|
n/a
|
| O: 0.53%
H: 12.11%
C: 11.05%
license granted grant
NN, Inc. Reports Financial Results For Third Quarter 2021
Published: 2021-11-04 (Crawled : 21:00) - prnewswire.com
NNBR | $3.86 -1.03% -1.04% 210K
|
Producer Manufacturing
|
| O: -4.75%
H: 13.7%
C: 9.21%
financial results results
SPX Reports Third Quarter 2021 Results
Published: 2021-11-04 (Crawled : 13:00) - spx.com
GIC | $40.52 0.87% 0.0% 56K
|
Retail Trade
|
| O: -0.94%
H: 0.0%
C: 0.0%
SPXC | $116.23 -1.22% 0.0% 340K
|
Producer Manufacturing
|
| O: -6.56%
H: 9.27%
C: 9.0%
results
TG Therapeutics Highlights Data Selected for Presentation at the 63rd American Society of Hematology (ASH) Annual Meeting
Published: 2021-11-04 (Crawled : 14:00) - globenewswire.com
TGTX | $13.79 -1.43% -1.45% 3.7M
|
Health Technology
|
| O: -2.37%
H: 8.96%
C: 8.47%
presentation ema
IGM Biosciences Announces Third Quarter 2021 Financial Results and Provides Corporate Update
Published: 2021-11-04 (Crawled : 14:00) - igmbio.com
IGMS | $7.2 -2.83% -2.92% 220K
|
Health Technology
|
| O: -9.65%
H: 10.43%
C: 8.35%
financial results results bioscience
Abstract #132: A Phase 1 Dose Escalation Study of IGM-2323, a Novel Anti-CD20 x Anti-CD3 IgM T Cell Engager (TCE) in Patients with Advanced B-Cell Malignancies
Published: 2021-11-04 (Crawled : 14:00) - igmbio.com
IGMS | $7.2 -2.83% -2.92% 220K
|
Health Technology
|
| O: -9.65%
H: 10.43%
C: 8.35%
anti-cd3 phase 1 t-cell
Birinapant clinical study initiated by IGM Biosciences
Published: 2021-11-04 (Crawled : 14:15) - prnewswire.com
IGMS | $7.2 -2.83% -2.92% 220K
|
Health Technology
|
| O: -9.65%
H: 10.43%
C: 8.35%
initiated bioscience
Multimeric IgM Antibodies Targeting DR5 are Potent and Rapid Inducers of Tumor Cell Apoptosis In Vitro and In Vivo
Published: 2021-11-04 (Crawled : 17:00) - igmbio.com
IGMS | $7.2 -2.83% -2.92% 220K
|
Health Technology
|
| O: -9.65%
H: 10.43%
C: 8.35%
antibody in vitro
Green Plains Partners Reports Third Quarter 2021 Financial Results
Published: 2021-11-04 (Crawled : 13:00) - globenewswire.com
GPRE 4 | $22.21 5.06% 4.82% 4.8M
|
Process Industries
|
| O: -3.65%
H: 8.63%
C: 8.33%
GPP 4 | $12.31 0.73% 260K
|
Transportation
|
| O: -3.95%
H: 0.0%
C: 0.0%
financial results results
Atara Biotherapeutics Announces Third Quarter 2021 Financial Results and Operational Progress
Published: 2021-11-04 (Crawled : 12:00) - biospace.com/
ATRA | $0.6755 -2.34% -2.4% 1.6M
|
Health Technology
|
| O: 6.25%
H: 9.09%
C: 8.27%
financial results results iot
Atara Biotherapeutics to Present Eight Abstracts at the 63rd American Society of Hematology (ASH) Annual Meeting, Including First Presentation of Tab-cel® Pivotal Phase 3 (ALLELE) Data
Published: 2021-11-04 (Crawled : 16:00) - biospace.com/
ATRA | $0.6755 -2.34% -2.4% 1.6M
|
Health Technology
|
| O: 6.25%
H: 9.09%
C: 8.27%
presentation ema tab-cel phase 3 iot cel
Dogness Completes Over $1 Million in Pet-Tech Shipments to a Major U.S. Retailer to Meet Increased Holiday Demand
Published: 2021-11-04 (Crawled : 13:00) - prnewswire.com
DOGZ | $6.63 -1.19% -1.21% 20K
|
Consumer Non-Durables
|
| O: -2.34%
H: 14.11%
C: 8.13%
ema
Dicerna Presents PHYOX™2 and Primary Hyperoxaluria Healthcare Utilization Data at American Society of Nephrology (ASN) Kidney Week 2021
Published: 2021-11-04 (Crawled : 18:00) - biospace.com/
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 0.06%
H: 0.26%
C: 0.19%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 3.16%
H: 0.0%
C: 0.0%
ALNY | $144.315 -0.58% -0.59% 700K
|
Health Technology
|
| O: -0.24%
H: 7.69%
C: 7.59%
kidney
Citizens Announces Q3 2021 Financial Results
Published: 2021-11-04 (Crawled : 20:00) - prnewswire.com
CIA 4 | $2.03 1.0% 0.49% 54K
|
Finance
|
| O: -3.61%
H: 9.22%
C: 7.34%
financial results results
Ritchie Bros. reports third quarter 2021 results
Published: 2021-11-04 (Crawled : 21:00) - prnewswire.com
RBA | $72.61 0.17% 0.0% 530K
|
Commercial Services
|
| O: 0.99%
H: 9.6%
C: 7.18%
results
Harbor Custom Development, Inc. Authorizes New Stock Repurchase Program
Published: 2021-11-04 (Crawled : 13:00) - globenewswire.com
HCDI | $0.199 -24.47% 1.2M
|
Finance
|
| O: 12.5%
H: 46.38%
C: 6.76%
program
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
KUKE | $2.88 2.49% 7.64% 360K
|
CXM 4 | $11.34 -0.44% 4.27% 1.7M
|
Information
RNR 4 | $224.74 0.85% 3.52% 310K
|
Finance
BSBR | $5.25 2.54% 0.38% 430K
|
Finance
JOE 4 | $54.88 1.22% 0.22% 210K
|
Finance
MUSA 4 | $417.23 1.06% 0.01% 170K
|
Retail Trade
JBI 4 | $15.14 1.34% 0.0% 2.9M
|
SBS | $15.49 -1.59% -0.84% 4.6M
|
Utilities
ML 4 | $69.13 -4.48% -1.64% 110K
|
SG 4 | $20.65 -0.91% -2.14% 1.4M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.